AORT - Artivion Inc

AORT - Artivion Inc

https://artivion.com

Buy Momentum: Bearish

Recent News

Powered by Alpha Vantage

Artivion ( AORT ) Tops Q2 Earnings and Revenue Estimates

Zacks Commentary • 1 month, 1 week ago • score: 0.21

Artivion (AORT) delivered earnings and revenue surprises of +118.18% and +4.36%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Artivion, Inc. Customers Whose Data May Have Been Compromised

Benzinga • 2 months ago • score: 0.02

NEWTOWN, Pa., July 13, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at Artivion, Inc. ( "Artivion" ) . Artivion learned of a data breach on or about November 20, 2024. If you would like to discuss this case with ...

This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Artivion ( NYSE:AORT ) , Coinbase Global ( NASDAQ:COIN )

Benzinga • 2 months, 4 weeks ago • score: 0.15

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Canaccord Genuity analyst William Plovanic initiated coverage on Artivion, Inc.

Artivion ( AORT ) Lags Q1 Earnings Estimates

Zacks Commentary • 4 months, 1 week ago • score: 0.08

Artivion (AORT) delivered earnings and revenue surprises of -50% and 4.19%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Strength Seen in Artivion ( AORT ) : Can Its 7.9% Jump Turn into More Strength?

Zacks Commentary • 5 months ago • score: 0.04

Artivion (AORT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Do Options Traders Know Something About Artivion ( AORT ) Stock We Don't?

Zacks Commentary • 5 months, 3 weeks ago • score: 0.14

Investors need to pay close attention to Artivion (AORT) stock based on the movements in the options market lately.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

Artivion Inc. manufactures, processes and distributes implantable human tissues and medical devices worldwide.

52W High

$45.07

52W Low

$21.97

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

1.70

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

56.82

EV/EBITDA (<8 favorable)

56.86

EV/Revenue (<3 favorable)

5.59

P/S (TTM) (<3 favorable)

5.07

P/B (<3 favorable)

4.89

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

4.50%

Institutions (25–75% balanced)

89.73%

Shares Outstanding

47,183,700

Float

41,609,900

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

2015-12-09

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

405,037,000

Gross Profit (TTM)

259,200,000

EPS (TTM)

-0.43

Profit Margin (>10% good)

-0.04%

Operating Margin (TTM) (higher better)

0.10%

ROE (TTM) (>15% strong)

-0.05%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.15

Momentum

Bearish momentum

Value

1.1766

Previous

1.5094

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025